{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:28:16Z","timestamp":1769574496935,"version":"3.49.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.euroneuro.2021.04.008","type":"journal-article","created":{"date-parts":[[2021,5,2]],"date-time":"2021-05-02T05:35:09Z","timestamp":1619933709000},"page":"23-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats"],"prefix":"10.1016","volume":"50","author":[{"given":"Vin\u00edcia Garzella","family":"Metz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9ssica Leandra Oliveira","family":"da Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenika Rubert","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Hautrive","family":"Milanesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilise Escobar","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila Simonetti","family":"Pase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2021.04.008_bib0001","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.nbd.2011.11.005","article-title":"Dopamine D1 receptor deletion strongly reduces neurotoxic effects of methamphetamine","volume":"45","author":"Ares-Santos","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.euroneuro.2021.04.008_bib0002","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.neuropharm.2010.05.011","article-title":"Withdrawal from chronic amphetamine produces persistent anxiety-like behavior but temporally-limited reductions in monoamines and neurogenesis in the adult rat dentate gyrus","volume":"59","author":"Barr","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0003","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0149-7634(97)00019-5","article-title":"Dopamine D1-like receptors and reward related incentive learning","volume":"22","author":"Beninger","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0004","first-page":"84","article-title":"Horizontal motor activity of hypertensive rats is associated with level of blood pressure","volume":"685","author":"Bernatova","year":"2011","journal-title":"Acta Physiol."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0005","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.euroneuro.2021.04.008_bib0006","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S2215-0366(19)30401-8","article-title":"Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis","volume":"6","author":"Black","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.04.008_bib0007","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s13311-015-0387-1","article-title":"Cannabidiol as a potential treatment for anxiety disorders","volume":"12","author":"Blessing","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"13","key":"10.1016\/j.euroneuro.2021.04.008_bib0008","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1038\/npp.2016.108","article-title":"Heightened dopaminergic response to amphetamine at the D3 dopamine receptor in methamphetamine users","volume":"41","author":"Boileau","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"14","key":"10.1016\/j.euroneuro.2021.04.008_bib0009","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.3390\/molecules24142583","article-title":"Cannabidiol treatment might promote resilience to cocaine and methamphetamine use disorders: a review of possible mechanisms","volume":"24","author":"Calpe-L\u00f3pez","year":"2019","journal-title":"Molecule"},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejphar.2016.03.040","article-title":"Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction","volume":"780","author":"Cao","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.008_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu025","article-title":"Chronic stimulation of the tone of endogenous anandamide reduces cue- and stress-induced relapse in rats","volume":"18","author":"Chauvet","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.euroneuro.2021.04.008_bib0012","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/s41386-020-0667-2","article-title":"Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials","volume":"45","author":"Chesney","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.euroneuro.2021.04.008_bib0013","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/npp.2011.230","article-title":"The neuropeptide Y (NPY)-ergic system is associated with behavioral resilience to stress exposure in an animal model of post-traumatic stress disorder","volume":"37","author":"Cohen","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0014","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/bs.pbr.2015.07.010","article-title":"Clinical neuroscience of amphetamine-type stimulants: from basic science to treatment development","volume":"223","author":"Courtney","year":"2016","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0015","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3389\/fimmu.2018.02009","article-title":"Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age","volume":"9","author":"Crippa","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.008_bib0017","doi-asserted-by":"crossref","first-page":"e12770","DOI":"10.1111\/adb.12770","article-title":"Parsing out the role of dopamine D4 receptor gene (DRD4) on alcohol-related phenotypes: a meta-analysis and systematic review","volume":"25","author":"Daurio","year":"2020","journal-title":"Addict. Biol."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.008_bib0018","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/adb.12366","article-title":"Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats","volume":"22","author":"de Carvalho","year":"2017","journal-title":"Addict. Biol."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.008_bib0019","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.euroneuro.2021.04.008_bib0020","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/bcpt.12821","article-title":"Could modafinil prevent psychostimulant addiction? An experimental study in rats","volume":"121","author":"Dias","year":"2017","journal-title":"Basic Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0021","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pnpbp.2019.01.007","article-title":"Modafinil reduces amphetamine preference and prevents anxiety-like symptoms during drug withdrawal in young rats: involvement of dopaminergic targets in VTA and striatum","volume":"92","author":"Dias","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.euroneuro.2021.04.008_bib0022","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pbb.2010.03.004","article-title":"Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L","volume":"95","author":"El-Alfy","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0023","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbr.2015.01.028","article-title":"Protective effects of cholecystokinin-8 on methamphetamine-induced behavioral changes and dopaminergic neurodegeneration in mice","volume":"283","author":"Gou","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0024","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/glia.21229","article-title":"Nrf2 deficiency potentiates methamphetamine-induced dopaminergic axonal damage and gliosis in the striatum","volume":"59","author":"Granado","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0025","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1124\/jpet.300.3.1093","article-title":"Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity","volume":"300","author":"Hansen","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.euroneuro.2021.04.008_bib0026","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1177\/0269881118799954","article-title":"Cannabidiol treatment reduces the motivation to self-administer methamphetamine and methamphetamine-primed relapse in rats","volume":"32","author":"Hay","year":"2018","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.04.008_bib0027","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s13311-015-0373-7","article-title":"Early phase in the development of cannabidiol as a treatment for addiction: opioid relapse takes initial center stage","volume":"12","author":"Hurd","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0028","series-title":"The Progress-Drive Hypothesis: An interpretation of Early Imitation","first-page":"361","author":"Kaplan","year":"2007"},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0029","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pnpbp.2017.08.022","article-title":"Cannabidiol inhibits priming-induced reinstatement of methamphetamine in REM sleep deprived rats","volume":"82","author":"Karimi-Haghighi","year":"2018","journal-title":"Progr. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.euroneuro.2021.04.008_bib0030","doi-asserted-by":"crossref","first-page":"e12740","DOI":"10.1111\/adb.12740","article-title":"Cannabidiol modulates the expression of neuroinflammatory factors in stress- and drug-induced reinstatement of methamphetamine in extinguished rats","volume":"25","author":"Karimi-Haghighi","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0031","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00210-006-0033-x","article-title":"Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors","volume":"372","author":"Kathmann","year":"2006","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib83","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nrn2234","article-title":"Synaptic plasticity and addiction.","volume":"8","author":"Kauer","year":"2007","journal-title":"Nature Reviews Neuroscience"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.008_bib0032","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00213-004-2074-5","article-title":"Angiotensin II blocks memory consolidation through an AT2 receptor-dependent mechanism","volume":"179","author":"Kerr","year":"2005","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.008_bib0033","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.008_bib0034","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrn3877","article-title":"Intrinsic plasticity: an emerging player in addiction","volume":"16","author":"Kourrich","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0035","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0036","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1167\/iovs.08-2196","article-title":"Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor","volume":"49","author":"Liou","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.euroneuro.2021.04.008_bib0037","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/s41401-018-0180-x","article-title":"Drug addiction: a curable mental disorder?","volume":"39","author":"Liu","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0038","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neuropharm.2018.09.043","article-title":"Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus","volume":"143","author":"Luj\u00e1n","year":"2018","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.008_bib0039","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/0269881116667706","article-title":"Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats","volume":"31","author":"Mahmud","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.04.008_bib0040","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/npp.2008.218","article-title":"Accruing preclinical evidence about metabotropic glutamate 5 receptor antagonists as treatments for drug dependence highlights the irreplaceable contributions of animal studies to the discovery of new medications for human disorders","volume":"34","author":"Markou","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0041","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1038\/sj.bjp.0706473","article-title":"Dopamine: the rewarding years","volume":"147","author":"Marsden","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.euroneuro.2021.04.008_bib0042","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/sj.npp.1301558","article-title":"Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors","volume":"33","author":"Mart\u00edn","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0043","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0044","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0045","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jnutbio.2019.02.007","article-title":"Omega-3 decreases D1 and D2 receptors expression in the prefrontal cortex and prevents amphetamine-induced conditioned place preference in rats","volume":"67","author":"Metz","year":"2019","journal-title":"J. Nutr. Biochem."},{"issue":"4","key":"10.1016\/j.euroneuro.2021.04.008_bib0046","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1037\/h0043788","article-title":"The relation between fear induced by novel stimulation and exploratory behavior","volume":"48","author":"Montgomery","year":"1955","journal-title":"J. Comp. Physiol. Psychol."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0047","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pneurobio.2015.09.011","article-title":"Amphetamine-related drugs neurotoxicity in humans and in experimental animals: main mechanisms","volume":"155","author":"Moratalla","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0048","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.lfs.2011.01.013","article-title":"Effects on sleep and dopamine levels of microdialysis perfusion of cannabidiol into the lateral hypothalamus of rats","volume":"88","author":"Murillo-Rodr\u00edguez","year":"2011","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.euroneuro.2021.04.008_bib0049","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1038\/npp.2016.93","article-title":"Cannabidiol modulates fear memory formation through interactions with serotonergic transmission in the mesolimbic system","volume":"41","author":"Norris","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fpsyt.2013.00109","article-title":"Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction","volume":"4","author":"Oli\u00e8re","year":"2013","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0051","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"issue":"47","key":"10.1016\/j.euroneuro.2021.04.008_bib0052","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a nonpsychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0053","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neubiorev.2017.02.006","article-title":"Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: implications for novel schizophrenia treatments","volume":"75","author":"Renard","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"10","key":"10.1016\/j.euroneuro.2021.04.008_bib0054","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/syn.20943","article-title":"Attenuated methamphetamine induced neurotoxicity by modafinil administration in mice","volume":"65","author":"Raineri","year":"2011","journal-title":"Synapse"},{"issue":"10","key":"10.1016\/j.euroneuro.2021.04.008_bib0055","doi-asserted-by":"crossref","first-page":"e46599","DOI":"10.1371\/journal.pone.0046599","article-title":"Modafinil abrogates methamphetamine-induced neuroinflammation and apoptotic effects in the mouse striatum","volume":"7","author":"Raineri","year":"2012","journal-title":"PLoS One"},{"issue":"47","key":"10.1016\/j.euroneuro.2021.04.008_bib0056","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1523\/JNEUROSCI.4291-09.2009","article-title":"Cannabidiol, a non psychotropic component of cannabis, inhibits cue-induced heroin seeking and normalizes discrete mesolimbic neuronal disturbances","volume":"29","author":"Ren","year":"2009","journal-title":"J. Neurosci."},{"issue":"18","key":"10.1016\/j.euroneuro.2021.04.008_bib0057","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1523\/JNEUROSCI.3387-15.2016","article-title":"Cannabidiol counteracts amphetamine-induced neuronal and behavioral sensitization of the mesolimbic dopamine pathway through a novel mTOR\/p70S6 kinase signaling pathway","volume":"36","author":"Renard","year":"2016","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.euroneuro.2021.04.008_bib0058","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00001756-199403000-00006","article-title":"Repeated stimulation of D1 dopamine receptors enhances (-)-11-hydroxy-delta 8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats","volume":"5","author":"Rodr\u00edguez de Fonseca","year":"1994","journal-title":"NeuroReports"},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0060","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"issue":"7","key":"10.1016\/j.euroneuro.2021.04.008_bib0061","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0062","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbr.2015.03.055","article-title":"Role of dopamine D1-like receptor within the nucleus accumbens in acute food deprivation- and drug priming-induced reinstatement of morphine seeking in rats","volume":"287","author":"Sadeghzadeh","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0063","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbr.2014.01.005","article-title":"Exercise modifies amphetamine relapse: behavioral and oxidative markers in rats","volume":"262","author":"Segat","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0064","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2015.11.002","article-title":"m-Trifluoromethyl-diphenyldiselenide as a pharmacological tool to treat preference symptoms related to AMPH-induced dependence in rats","volume":"66","author":"Segat","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresbull.2017.09.013","article-title":"Influence of physical activity on addiction parameters of rats exposed to amphetamine which were previously supplemented with hydrogenated vegetable fat","volume":"135","author":"Segat","year":"2017","journal-title":"Brain Res. Bul."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0066","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.neulet.2018.10.007","article-title":"Substitution therapy with amphetamine-isotherapic attenuates amphetamine toxicological aspects of addiction","volume":"690","author":"Segat","year":"2018","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.008_bib0067","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2478\/intox-2013-0020","article-title":"Determination of motor activity and anxiety-related behaviour in rodents: methodological aspects and role of nitric oxide","volume":"6","author":"Sestakova","year":"2013","journal-title":"Interdiscip. Toxicol."},{"issue":"1\u20132","key":"10.1016\/j.euroneuro.2021.04.008_bib0068","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.008_bib0069","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/157015911795017236","article-title":"The selective serotonin reuptake inhibitor paroxetine, but not fluvoxamine, decreases methamphetamine conditioned place preference in mice","volume":"9","author":"Takamatsu","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijdevneu.2014.12.001","article-title":"The neurotoxicity of amphetamines during the adolescent period","volume":"41","author":"Teixeira-Gomes","year":"2015","journal-title":"Int. J. Dev. Neurosci."},{"issue":"10","key":"10.1016\/j.euroneuro.2021.04.008_bib0071","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/bph.14440","article-title":"Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors","volume":"176","author":"Tham","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0072","unstructured":"UNODC \u2013 United Nations Office for Drug Control and Crime Prevention. World Drug Report, 2020."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0073","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbr.2006.02.022","article-title":"Brief early handling increases morphine dependence in adult rats","volume":"170","author":"Vasquez","year":"2006","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.008_bib0075","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41401-018-0032-8","article-title":"Cannabidiol does not display drug abuse potential in mice behavior","volume":"40","author":"Viudez-Mart\u00ednez","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.euroneuro.2021.04.008_bib0076","doi-asserted-by":"crossref","first-page":"e12765","DOI":"10.1111\/adb.12765","article-title":"Gender differences in the effects of cannabidiol on ethanol binge drinking in mice","volume":"25","author":"Viudez-Mart\u00ednez","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0077","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1471-4159.2006.04419.x","article-title":"The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine-induced dopaminergic d\u00e9ficits","volume":"101","author":"Volz","year":"2007","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.008_bib0078","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbr.2009.11.036","article-title":"Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism","volume":"208","author":"Vuong","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0079","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fphar.2017.00020","article-title":"In vivo evidence for therapeutic properties of cannabidiol (CBD) for Alzheimer's disease","volume":"8","author":"Watt","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.euroneuro.2021.04.008_bib0080","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.biopsych.2009.12.015","article-title":"Action of modafinil\u2014increased motivation via the dopamine transporter inhibition and D1 receptors?","volume":"67","author":"Young","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2021.04.008_bib0081","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","article-title":"Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors","volume":"159","author":"Zanelati","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"40","key":"10.1016\/j.euroneuro.2021.04.008_bib0082","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1523\/JNEUROSCI.1712-16.2016","article-title":"Drug-induced alterations of endocannabinoid-mediated plasticity in brain reward regions","volume":"36","author":"Zlebnik","year":"2016","journal-title":"J. Neurosci."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21001966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X21001966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:59:43Z","timestamp":1760378383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X21001966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":80,"alternative-id":["S0924977X21001966"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.04.008","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol prevents amphetamine relapse and modulates D1- and D2-receptor levels in mesocorticolimbic brain areas of rats","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2021.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}